Comment on: Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib - Advance

Please note: We are currently experiencing some performance issues across the site, and some pages may be slow to load. We are working on restoring normal service soon. Importing new articles from Word documents is also currently unavailable. We apologize for any inconvenience.

loading page

Comment on: Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib

Paige Vicenzi,
Anish Ray

06 Oct 2020Submission Checks Completed

06 Oct 2020Assigned to Editor

06 Oct 2020Submitted to Pediatric Blood & Cancer

07 Oct 2020Editorial Decision: Accept

21 Oct 2020Published in Pediatric Blood & Cancer. 10.1002/pbc.28776